Aflac Incorporated

Aflac Incorporated(AFL)股票分析

$116.020

+0.174 (+0.15%)收盘时

Loading chart…
High
117.350
Open
116.760
VWAP
116.08
Vol
3.16M
Mkt Cap
50.66B
Low
114.860
Amount
366.69M
EV/EBITDA, TTM
14.50

Aflac Incorporated provides financial protection to policyholders and customers through its subsidiaries in the United States and Japan. The Company's principal business is supplemental health and life insurance products. Its segments include Aflac Japan, which includes Aflac Life Insurance Japan Ltd. (ALIJ), and Aflac U.S., which includes American Family Life Assurance Company of Columbus (Aflac), American Family Life Assurance Company of New York (Aflac New York), Continental American Insurance Company (CAIC), Tier One Insurance Company (TOIC), and Aflac Benefits Solutions, Inc. (ABS). The Aflac Japan segment is the insurer in Japan in terms of cancer and medical (third sector insurance products) policies in force. The Company designs its United States insurance products to provide supplemental coverage for people who already have major medical or primary insurance coverage, as Aflac U.S. insurance policies pay benefits regardless of other insurance.

www.aflac.com

AI analysis of Aflac Incorporated (AFL)

hold

Aflac Inc is currently priced at $116.52, with a forward P/E of 14.53, which is relatively low compared to the market average. However, the RSI is at 35.76, indicating that the stock is in the oversold territory, suggesting potential for a rebound. The main risk is the 6.9% year-over-year decline in Q2 sales, which reflects challenges in the Japanese market and could impact future growth. Overall, while there are some positive indicators, the current sales decline and mixed analyst ratings suggest holding rather than buying.

Analyst Ratings (15)

-4.41% downside
Hold
3 Buy
10 Hold
2 Sell
Current: 116.02
最低
100.00
平均
110.90
最高
125.00

Wells Fargo

2026-08-19

目标价

$122

Equal Weight

Wolfe Research

2026-08-19

目标价

$103

Underperform

JPMorgan

2026-08-11

目标价

$116

Neutral

Keefe Bruyette

2026-08-11

目标价

$125

Market Perform

Mizuho

2026-08-10

目标价

$116

Underperform

估值指标

The current forward P/E ratio for Aflac Incorporated (AFL) is 14.53, compared to its 5-year average forward P/E of 13.26.

Forward P/E

Fair
5Y Average P/E
13.26
Current P/E
14.53
高估
15.00
低估
11.52

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
-22.32
Current EV/EBITDA
14.50
高估
60.17
低估
-104.80

Forward P/S

Overvalued
5Y Average P/S
2.76
Current P/S
3.39
高估
3.33
低估
2.19

Alphio AI Price Scenarios for AFL

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%AFL

$128.92

情景价格

B

Base

Base · 50%AFL

$107.08

情景价格

B

Bear

Bear · 25%AFL

$100.33

情景价格

Whales holding AFL

T

Turtle Creek Management, LLC

+ HoldingAFL

+18.74%

3M Return

S

Synovus Trust Company, National Association

+ HoldingAFL

+8.04%

3M Return

S

S & Co., Inc.

+ HoldingAFL

+3.92%

3M Return

W

Waters, Parkerson & Co., LLC

+ HoldingAFL

+1.98%

3M Return

S

Sterling Capital Management LLC

+ HoldingAFL

+1.53%

3M Return

D

Destination Wealth Management

+ HoldingAFL

+1.44%

3M Return

AFL FAQ — answered by Alphio AI

Aflac Incorporated provides financial protection to policyholders and customers through its subsidiaries in the United States and Japan. The Company's principal business is supplemental health and life insurance products. Its segments include Aflac Japan, which includes Aflac Life Insurance Japan Ltd. (ALIJ), and Aflac U.S., which includes American Family Life Assurance Company of Columbus (Aflac), American Family Life Assurance Company of New York (Aflac New York), Continental American Insurance Company (CAIC), Tier One Insurance Company (TOIC), and Aflac Benefits Solutions, Inc. (ABS). The Aflac Japan segment is the insurer in Japan in terms of cancer and medical (third sector insurance products) policies in force. The Company designs its United States insurance products to provide supplemental coverage for people who already have major medical or primary insurance coverage, as Aflac U.S. insurance policies pay benefits regardless of other insurance. It operates in the Financials sector (ACCIDENT & HEALTH INSURANCE industry).

Aflac Inc is currently priced at $116.52, with a forward P/E of 14.53, which is relatively low compared to the market average. However, the RSI is at 35.76, indicating that the stock is in the oversold territory, suggesting potential for a rebound. The main risk is the 6.9% year-over-year decline in Q2 sales, which reflects challenges in the Japanese market and could impact future growth. Overall, while there are some positive indicators, the current sales decline and mixed analyst ratings suggest holding rather than buying.

15 analysts cover AFL: 3 rate it Buy, 10 Hold and 2 Sell. The average price target is 110.90.

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

免费开始